|
Pronunciation |
|
(pen
i SIL in jee BENZ a theen &
PROE kane KOM bined) |
|
|
U.S. Brand
Names |
|
Bicillin® C-R 900/300 Injection;
Bicillin® C-R
Injection |
|
|
Generic
Available |
|
No |
|
|
Synonyms |
|
Penicillin G Procaine and Benzathine Combined |
|
|
Pharmacological Index |
|
Antibiotic, Penicillin |
|
|
Use |
|
May be used in specific situations in the treatment of streptococcal
infections |
|
|
Pregnancy Risk
Factor |
|
B |
|
|
Contraindications |
|
Known hypersensitivity to penicillin or any component |
|
|
Warnings/Precautions |
|
Use with caution in patients with impaired renal function, impaired cardiac
function or seizure disorder |
|
|
Adverse
Reactions |
|
1% to 10%:
Hematologic: Positive Coombs' reaction, hemolytic anemia
Renal: Interstitial nephritis
Miscellaneous: Hypersensitivity reactions, Jarisch-Herxheimer reaction
|
|
|
Overdosage/Toxicology |
|
Many beta-lactam-containing antibiotics have the potential to cause
neuromuscular hyperirritability or convulsive seizures
Hemodialysis may be helpful to aid in the removal of the drug from the blood,
otherwise most treatment is supportive or symptom directed |
|
|
Drug
Interactions |
|
Probenecid, tetracyclines, methotrexate, aminoglycosides |
|
|
Stability |
|
Store in the refrigerator |
|
|
Mechanism of
Action |
|
Inhibits bacterial cell wall synthesis by binding to one or more of the
penicillin binding proteins (PBPs); which in turn inhibits the final
transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus
inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing
activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while
cell wall assembly is arrested. |
|
|
Usual Dosage |
|
I.M.:
<30 lb: 600,000 units in a single dose
30-60 lb: 900,000 units to 1.2 million units in a single dose
Children >60 lb and Adults: 2.4 million units in a single dose
|
|
|
Administration |
|
Administer by deep I.M. injection in the upper outer quadrant of the buttock;
give around-the-clock rather than 4 times/day, 3 times/day, etc, (ie, 12-6-12-6,
not 9-1-5-9) to promote less variation in peak and trough serum levels; do
not administer I.V., intravascularly, or intra-arterially. In infants and
children, I.M. injections should be made into the midlateral muscle of the
thigh. |
|
|
Monitoring
Parameters |
|
Observe for signs and symptoms for anaphylaxis during first
dose |
|
|
Test
Interactions |
|
May interfere with urinary glucose tests using cupric sulfate (Benedict's
solution, Clinitest®); may inactivate aminoglycosides
in vitro; positive Coombs' [direct], increased protein |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Nursing
Implications |
|
Administer by deep I.M. injection in the upper outer quadrant of the
buttock |
|
|
Dosage Forms |
|
Injection:
300,000 units [150,000 units each of penicillin g benzathine and penicillin g
procaine] (10 mL)
600,000 units [300,000 units each penicillin g benzathine and penicillin g
procaine] (1 mL)
1,200,000 units [600,000 units each penicillin g benzathine and penicillin g
procaine] (2 mL)
2,400,000 units [1,200,000 units each penicillin g benzathine and penicillin
g procaine] (4 mL)
Injection: Penicillin g benzathine 900,000 units and penicillin g procaine
300,000 units per dose (2 mL) |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|